7 FP BIOTECHNOLOGY GENERIC TOOLS AND MEDICAL TECHNOLOGIES
7 FP • • • BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH TRANSLATING RESEARCH FOR HUMAN HEALTH – Large-scale data gathering and Systems biology – Brain and brain-related diseases and Human development and ageing – Translational research in major infectious diseases (Anti-microbial drug resistance, HIV/AIDS, malaria and tuberculosis) – Translational research in other major diseases (Cancer, Cardiovascular diseases, Diabetes and obesity) OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS HORIZON 2020 • Understanding health, ageing and disease; • Effective health promotion, disease prevention, preparedness and screening; • Improving diagnosis • Innovative treatments and technologies • Advancing active and healthy ageing • Integrated, sustainable, citizencentred care • Improving heath information, data exploitation and providing an evidence base for health policies and regulation
Deadline PHC 21 - 2015 PHC 25 - 2015 PHC 27 – 2015 PHC 28 – 2015 PHC 29 – 2015 PHC 30 - 2015 21 апреля 2015 года http: //ec. europa. eu/research/participants/data/ref/h 2020/wp/2014_2015/main /h 2020 -wp 1415 -health_en. pdf
e. Health PHC 21 – 2015: Advancing active and healthy ageing with ICT: Early risk detection and intervention PHC 25 – 2015: Advanced ICT systems and services for Integrated Care PHC 27 – 2015: Self-management of health and disease and patient empowerment supported by ICT PHC 28 – 2015: Self-management of health and disease and decision support systems based on predictive computer modelling used by the patient him or herself PHC 29 – 2015: Public procurement of innovative e. Health services PHC 30 – 2015: Digital representation of health data to improve disease diagnosis and treatment HORIZON 2020
#Horizon. Prize • The European Commission has Horizon Prize for Better use of Antibiotics launched the • This challenge prize is offering a cash reward of € 1 million • To the person/team meeting the following challenge: Develop a rapid test that will allow healthcare providers to distinguish, at the point-of-care, between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without them. • These infections include pharyngitis, sinusitis, otitis and bronchitis. Research and Innovation
#Horizon. Prize Objectives of the Prize • Reduce the unnecessary use of antibiotics in case of viral upper respiratory tract infections; • Reduce costs and side effects linked to the use of antibiotics; • Delay emergence of antibiotic-resistant organisms. Research and Innovation
#Horizon. Prize How can the challenge be met? • As a minimum, the test needs to be cheap, rapid, easy-to-use for healthcare providers and non- or minimally invasive for patients. Timeline • Deadline for submissions: 17/08/2016 Award decision at the end of 2016. • Website: www. ec. europa. eu/horizonprize/antibiotics Research and Innovation
- Slides: 11